loader image
Tuesday, December 23, 2025
69 F
McAllen
- Advertisement -

Strength Training Effective for Managing Blood Pressure, Study Finds

Translate to Spanish or other 102 languages!

Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes
Strength training may be a noninvasive way to manage high blood pressure, a study suggests. Image for illustration purposes

Medical News Today

- Advertisement -
  • High blood pressure or hypertension is a common condition that can lead to serious problems without proper management. 
  • High blood pressure management can involve using medications and lifestyle modifications. 
  • Data from a systematic review and meta-analysis found that strength training may be an effective non-medication option for the management of high blood pressure. However, its effectiveness depends on factors like intensity level and duration.

Follow the link below to read the full story on Medical News Today: https://www.medicalnewstoday.com/articles/hypertension-strength-training-helps-manage-high-blood-pressure?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-04-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Offers 10 Health Recommendations for the New Year

As the new year quickly approaches, the American Medical Association (AMA) is offering 10 recommendations to help Americans make the most impactful, long-lasting improvements to their health in 2026 and beyond.

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.
- Advertisement -
×